FDP-18720-08809
3 vaccinations
9 coded responses
25 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 442 / OH
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
NSP-14556-09474
Child or adolescent in my care · Male · 2021-12-24
Timeline
-
2021-03-23
Registered in v-safe
-
2021-03-23
Dose 1 — Pfizer-BioNTech
-
2021-03-23
Survey response — day 0, dose 1MedDRA: Dizziness, Flushing — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection siteFree text: Flushing of the face and dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Flushing — Feeling: Good · Site: Swelling · Fatigue or tirednessFree text: Facial flushingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
-
2021-03-26
Survey response — days 1–6 daily, dose 1MedDRA: Flushing — Feeling: Good · Fatigue or tirednessFree text: Mild facial flushingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-30
- 2021-04-06
-
2021-04-13
Dose 2 — Pfizer-BioNTech
-
2021-04-13
Survey response — day 0, dose 2MedDRA: Chills, Immediate post-injection reaction, Nausea — Feeling: GoodFree text: Mild nausea and chills about 20 minutes after shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-15
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-17
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-04-22
Health check-in — day 7, dose 2Feeling: Good · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-27
Survey response — day 14, dose 2MedDRA: Diarrhoea, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diarrhea and fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Survey response — day 21, dose 2MedDRA: Condition aggravated, Fatigue, Headache, Myalgia, Night sweats, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Night sweats, headache, fatigue, muscle aches, tiredness. One week after my first shot a fibromyalgia flare up started...and is still happeningMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Survey response — day 28, dose 2MedDRA: Feeling cold, Flushing, Hot flush — Feeling: Good · Be unable to do your normal daily activitiesFree text: Hot and cold flashes and facial flushingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Survey response — day 35, dose 2MedDRA: Fatigue, Flushing — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Fatigue and tiredness is relentless and still having flushing of my faceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-26
- 2021-07-15
-
2021-09-27
Dose 3 — Pfizer-BioNTech
- 2021-10-14
- 2022-03-28
-
2022-09-27
Survey response — 12 months, dose 3MedDRA: Thyroid cancer — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Thyroid cancerMedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-09-28
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Flushing of the face and dizziness
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Facial flushing
Systemic reaction (other): Mild facial flushing
Release 7 — day 0, dose 2
Systemic reaction (other): Mild nausea and chills about 20 minutes after shot
Release 8 — day 14, dose 2
Symptoms: Diarrhea and fatigue
Release 8 — day 21, dose 2
Symptoms: Night sweats, headache, fatigue, muscle aches, tiredness. One week after my first shot a fibromyalgia flare up started...and is still happening
Release 8 — day 28, dose 2
Symptoms: Hot and cold flashes and facial flushing
Release 8 — day 35, dose 2
Symptoms: Fatigue and tiredness is relentless and still having flushing of my face
Release 12 — 12 months, dose 3
Symptoms: Thyroid cancer
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling cold | ✓ | ✓ | ✓ |
| SD | Flushing | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hot flush | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Night sweats | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Thyroid cancer | · | · | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | · | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release